At a glance
- Originator Antigenics
- Class Antivirals; Nucleosides; Small molecules
- Mechanism of Action DNA synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hepatitis B
Most Recent Events
- 07 May 1998 Discontinued-Preclinical for Hepatitis B in USA (Unknown route)
- 09 Apr 1996 New profile
- 09 Apr 1996 Preclinical development for Hepatitis B in USA (Unknown route)